Top Markets
Coin of the day
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Ранг среди акций #33959
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Цена акции
$17.15
Последняя синхронизация: 2026-08-03
Рыночная капитализация
$6.51M
Изменение (1 день)
9.80%
Изменение (1 год)
289.77%
Страна
US
Торговля Galera Therapeutics, Inc. (GRTX)

Категория

Количество находящихся в обращении акций Galera Therapeutics, Inc. (GRTX)
Количество акций в обращении на March 2026: 98.62M
Согласно последним финансовым отчетам и цене акций Galera Therapeutics, Inc., текущее количество акций в обращении составляет 98.62M. На конец December 2023 у компании было 44.55M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Galera Therapeutics, Inc. (GRTX) с 2017 по 2026
Акции в обращении на конец каждого года
Год Акции в обращении Изменить
2026 (TTM) 98.62M 80.52%
2024 54.63M 22.64%
2023 44.55M 64.47%
2022 27.09M 5.03%
2021 25.79M 3.70%
2020 24.87M 0.24%
2019 24.81M 28.15%
2018 19.36M -98.73%
2017 1.52B 0.00%
Акции в обращении у аналогичных компаний или конкурентов
Компания Акции в обращении Разница Страна
253.90M 157.45%
US
62.19M -36.95%
NL
- -
CH
- -
KR
0.00 -100.00%
BE